Berto, P. (2022) “Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy”, Farmeconomia. Health economics and therapeutic pathways, 23(1). doi: 10.7175/fe.v23i1.1516.